Analysts predict that Hill-Rom Holdings, Inc. (NYSE:HRC) will report earnings of $1.08 per share for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Hill-Rom’s earnings, with estimates ranging from $1.07 to $1.09. Hill-Rom posted earnings per share of $1.02 during the same quarter last year, which indicates a positive year-over-year growth rate of 5.9%. The company is expected to issue its next quarterly earnings report on Friday, January 24th.
According to Zacks, analysts expect that Hill-Rom will report full year earnings of $5.52 per share for the current year, with EPS estimates ranging from $5.51 to $5.54. For the next financial year, analysts forecast that the firm will post earnings of $6.16 per share, with EPS estimates ranging from $6.00 to $6.25. Zacks’ EPS calculations are an average based on a survey of research firms that that provide coverage for Hill-Rom.
Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, November 1st. The medical technology company reported $1.69 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.65 by $0.04. The firm had revenue of $782.80 million during the quarter, compared to analysts’ expectations of $759.14 million. Hill-Rom had a net margin of 5.24% and a return on equity of 21.67%. Hill-Rom’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.63 earnings per share.
In other news, SVP Andreas G. Frank sold 6,000 shares of Hill-Rom stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $105.83, for a total value of $634,980.00. Following the transaction, the senior vice president now directly owns 40,004 shares in the company, valued at $4,233,623.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Deborah Rasin sold 4,739 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $103.97, for a total value of $492,713.83. Following the transaction, the senior vice president now directly owns 31,001 shares of the company’s stock, valued at approximately $3,223,173.97. The disclosure for this sale can be found here. 0.73% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. United Services Automobile Association boosted its position in shares of Hill-Rom by 0.6% in the second quarter. United Services Automobile Association now owns 21,608 shares of the medical technology company’s stock valued at $2,261,000 after acquiring an additional 132 shares during the period. Whittier Trust Co. grew its stake in shares of Hill-Rom by 29.8% in the third quarter. Whittier Trust Co. now owns 649 shares of the medical technology company’s stock worth $68,000 after acquiring an additional 149 shares during the last quarter. Texas Permanent School Fund increased its position in Hill-Rom by 0.4% during the third quarter. Texas Permanent School Fund now owns 45,477 shares of the medical technology company’s stock worth $4,786,000 after acquiring an additional 160 shares during the period. Bay Harbor Wealth Management LLC increased its position in Hill-Rom by 31.8% during the third quarter. Bay Harbor Wealth Management LLC now owns 705 shares of the medical technology company’s stock worth $72,000 after acquiring an additional 170 shares during the period. Finally, Flagship Harbor Advisors LLC raised its stake in Hill-Rom by 8.4% during the 3rd quarter. Flagship Harbor Advisors LLC now owns 2,254 shares of the medical technology company’s stock valued at $237,000 after purchasing an additional 174 shares during the last quarter. 82.85% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NYSE:HRC traded up $0.60 on Wednesday, reaching $106.61. The company had a trading volume of 11,320 shares, compared to its average volume of 379,511. Hill-Rom has a twelve month low of $81.85 and a twelve month high of $111.63. The stock has a 50-day moving average price of $103.67 and a 200 day moving average price of $103.77. The stock has a market capitalization of $7.16 billion, a P/E ratio of 21.01, a P/E/G ratio of 1.66 and a beta of 0.82. The company has a quick ratio of 1.10, a current ratio of 1.31 and a debt-to-equity ratio of 1.13.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. Hill-Rom’s payout ratio is 16.54%.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Recommended Story: Basic Economics creates winners and losers
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.